Northstar Investment Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $961K | Buy |
22,448
+1,875
| +9% | +$72.9K | 0.13% | 105 |
|
|
2021
Q1 | $745K | Hold |
20,573
| – | – | 0.11% | 106 |
|
|
2020
Q4 | $757K | Sell |
20,573
-373
| -2% | -$13.7K | 0.12% | 96 |
|
|
2020
Q3 | $729K | Sell |
20,946
-13,650
| -39% | -$479K | 0.13% | 90 |
|
|
2020
Q2 | $1.07M | Hold |
34,596
| – | – | 0.23% | 80 |
|
|
2020
Q1 | $1.07M | Hold |
34,596
| – | – | 0.27% | 76 |
|
|
2019
Q4 | $1.29M | Hold |
34,596
| – | – | 0.2% | 89 |
|
|
2019
Q3 | $1.17M | Buy |
34,596
+16,864
| +95% | +$613K | 0.19% | 84 |
|
|
2019
Q2 | $729K | Sell |
17,732
-2,783
| -14% | -$111K | 0.13% | 85 |
|
|
2019
Q1 | $827K | Buy |
20,515
+227
| +1% | +$9.09K | 0.15% | 85 |
|
|
2018
Q4 | $840K | Buy |
20,288
+3,794
| +23% | +$157K | 0.18% | 73 |
|
|
2018
Q3 | $690K | Sell |
16,494
-97
| -0.6% | -$3.73K | 0.14% | 70 |
|
|
2018
Q2 | $568K | Sell |
16,591
-1,516
| -8% | -$51.8K | 0.12% | 74 |
|
|
2018
Q1 | $610K | Hold |
18,107
| – | – | 0.13% | 69 |
|
|
2017
Q4 | $622K | Sell |
18,107
-210
| -1% | -$7.16K | 0.11% | 74 |
|
|
2017
Q3 | $620K | Buy |
18,317
+203
| +1% | +$6.52K | 0.12% | 75 |
|
|
2017
Q2 | $577K | Buy |
18,114
+4,174
| +30% | +$132K | 0.12% | 75 |
|
|
2017
Q1 | $452K | Sell |
13,940
-340
| -2% | -$10.7K | 0.09% | 78 |
|
|
2016
Q4 | $440K | Buy |
14,280
+340
| +2% | +$10.4K | 0.1% | 77 |
|
|
2016
Q3 | $429K | Buy |
13,940
+701
| +5% | +$23.4K | 0.1% | 79 |
|
|
2016
Q2 | $442K | Sell |
13,239
-90
| -0.7% | -$2.87K | 0.1% | 77 |
|
|
2016
Q1 | $375K | Buy |
13,329
+90
| +0.7% | +$2.57K | 0.09% | 77 |
|
|
2015
Q4 | $405K | Hold |
13,239
| – | – | 0.1% | 77 |
|
|
2015
Q3 | $395K | Sell |
13,239
-4,216
| -24% | -$135K | 0.11% | 80 |
|
|
2015
Q2 | $555K | Buy |
17,455
+4,216
| +32% | +$137K | 0.14% | 76 |
|
|
2015
Q1 | $437K | Sell |
13,239
-4,571
| -26% | -$145K | 0.11% | 78 |
|
|
2014
Q4 | $526K | Buy |
17,810
+355
| +2% | +$10.2K | 0.13% | 79 |
|
|
2014
Q3 | $490K | Sell |
17,455
-4,701
| -21% | -$132K | 0.13% | 79 |
|
|
2014
Q2 | $624K | Sell |
22,156
-1,518
| -6% | -$43.3K | 0.16% | 77 |
|
|
2014
Q1 | $721K | Hold |
23,674
| – | – | 0.19% | 75 |
|
|
2013
Q4 | $688K | Buy |
23,674
+4,385
| +23% | +$128K | 0.19% | 76 |
|
|
2013
Q3 | $526K | Hold |
19,289
| – | – | 0.16% | 77 |
|
|
2013
Q2 | $513K | Buy |
+19,289
| New | +$533K | 0.16% | 75 |
|
Other funds holding PFE
Northstar Investment Advisors's PFE Position: Q2 2021 in Review
Northstar Investment Advisors increased its Pfizer (PFE) stake by 9.1% in Q2 2021, buying an estimated $72.9K and bringing the position to 22,448 shares worth $961K. The position accounts for 0.13% of the portfolio, ranked #105.
Northstar Investment Advisors first reported a position in PFE in Q2 2013 and has held it in 33 quarters since. The position peaked at $1.29M in Q4 2019. 2,732 funds tracked by Wall St. Rank hold PFE as of Q2 2021.
- Northstar Investment Advisors held 22,448 shares of Pfizer worth $961K as of Q2 2021.
- Northstar Investment Advisors bought 1,875 Pfizer shares in Q2 2021, an estimated $72.9K.
- Pfizer made up 0.13% of Northstar Investment Advisors's portfolio in Q2 2021, its #105 holding.
- Northstar Investment Advisors first reported a position in Pfizer in Q2 2013 and has held it in 33 quarters since.
- Northstar Investment Advisors's Pfizer position peaked at $1.29M in Q4 2019.
- 2,732 funds tracked by Wall St. Rank held Pfizer as of Q2 2021.
Based on Northstar Investment Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.